Brief: Relief Therapeutics Shareholders Approve Business Combination With Neurox
14/11/2025 17:24
Nov 14 (Reuters) - Relief Therapeutics Holding SA RLFB.S: RELIEF THERAPEUTICS SHAREHOLDERS APPROVE BUSINESS COMBINATION WITH NEUROX RELIEF THERAPEUTICS HOLDING SA - ALEXANDRE CAPET EXPECTED TO SERVE AS CEO RELIEF THERAPEUTICS HOLDING SA - TO BE RENAMED MINDMAZE THERAPEUTICS HOLDING SA Source text: ID:nEQ6Gpk9Ja Further company coverage: RLFB.S ((Reuters.briefs@thomsonreuters.com;))
Recent news on MindMaze Therapeutics Holding SA
See all newsBrief: Mindmaze Therapeutics Announces CHF 8.0 Million Strategic Equity Financing
Brief: Relief Therapeutics Shareholders Approve Business Combination With Neurox
Brief: Relief Therapeutics Receives FDA Response To Qidp Request For Rlf-Td011
Brief: Relief Therapeutics Says Interim CEO Michelle Lock Has Completed Her Transitional Mandate
Swiss stocks - Factors to watch on May 13